Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Apotekeren A.m.b.a.
ABA
Active
CVR 16938106
Fruebjergvej 3, 2100
København Ø
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1993 · 33 years old
20 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Apotekeren A.m.b.a.
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
97M
73M
49M
24M
0M
2021: 72M
72M
2021
2022: 70M (-3% vs 2021)
70M
-3%
2022
2023: 78M (+11% vs 2022)
78M
+11%
2023
2024: 75M (-4% vs 2023)
75M
-4%
2024
2025: 75M (0% vs 2024)
75M
0%
2025
EBITDA
DKK millions
86M
64M
43M
21M
0M
2021: 63M
63M
2021
2022: 61M (-3% vs 2021)
61M
-3%
2022
2023: 69M (+13% vs 2022)
69M
+13%
2023
2024: 65M (-6% vs 2023)
65M
-6%
2024
2025: 65M (0% vs 2024)
65M
0%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
75.346
74.631
78.436
70.097
71.658
Staff expenses
-10.220
-9.719
-8.944
-8.719
-8.335
EBITDA
65.126
64.912
69.492
61.378
63.323
Depreciation & amort.
-218
-291
-72
-0
-0
EBIT
64.908
64.621
69.420
61.378
63.323
Net financials
132
618
66
-278
-225
Profit before tax
65.040
65.239
69.485
61.101
63.098
Tax
0
0
0
0
-1
Net profit
65.040
65.239
69.485
61.101
63.098
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
44.699
45.491
51.458
43.877
47.558
Equity
42.277
43.259
49.493
42.273
45.731
Long-term debt
0
0
0
0
0
Short-term debt
2.422
2.231
1.964
1.604
1.827
Total debt
2.422
2.231
1.964
1.604
1.827
Financial ratios
5-year trend
EBITDA margin (of gross profit)
86,4 %
This company
2021
2025
Equity ratio
94,6 %
This company
38,2 %
Market median
This company
Market median
148% above market
2021
2025
Return on equity
153,8 %
This company
18,4 %
Market median
This company
Market median
736% above market
2021
2025
Net profit margin (of gross profit)
86,3 %
This company
2021
2025
Asset turnover (of gross profit)
1,69×
This company
2021
2025
Debt / equity
0,06×
This company
0,62×
Market median
This company
Market median
90% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Apotekeren A.m.b.a.
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
